Skip to content

The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache

The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00574015
Enrollment
18
Registered
2007-12-14
Start date
2007-12-31
Completion date
2013-01-31
Last updated
2014-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Toothache

Keywords

toothache, regional anesthesia, emergency department

Brief summary

This study will compare the degree of pain control provided by two techniques for persons with toothache in an emergency department. The two techniques include; * standard oral narcotic pain medication * numbing the tooth with local anesthetic by needle injection

Detailed description

Background: Toothache is a common complaint among patients presenting to the emergency department. There are two commonly employed methods of alleviating this severe form of pain. Oral opioid analgesia is the most commonly utilized strategy for treating this pain. However, many emergency physicians and dentists employ a local anesthetic technique known as supraperiosteal nerve block. This study will compare the relative efficacy of these techniques. Patients meeting enrollment criteria will be randomized to either receive a supraperiosteal nerve block or oral hydrocodone 10 mg/acetaminophen 650 mg. They will otherwise be managed identically. Reduction of pain scores between entry and 30 minutes post intervention will be compared as well as numeric pain scores obtained by phone contact 24 hours later. Secondary outcomes will include the proportion of individuals from each group filling prescriptions for pain medication and the number of pain pills taken.

Interventions

oral hydrocodone 10 mg/acetaminophen 650 mg

DRUGbupivacaine (supraperiosteal nerve block)

Administration of Bupivacaine 0.5% 2 ml adjacent to tooth root

Sponsors

Albany Medical College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Involvement of a single tooth * Percussive tenderness of the crown of the suspect tooth

Exclusion criteria

* Age younger than 18 years * Women who are breast feeding * Allergy or intolerance to hydrocodone, bupivacaine or acetaminophen * Pregnancy * Involvement of multiple teeth * Pain resulting from pericoronitis. * Pain resulting from dental trauma occurring less than 90 days prior * Pain of more than 96 hours duration * Facial or neck swelling or tenderness * Alteration in phonation * Cognitive impairment * Concurrent use of opiate analgesics * Impairment of liver function * Consumption of more than 4 grams of acetaminophen in the past 24 hours. * Patients who are visually impaired.

Design outcomes

Primary

MeasureTime frame
VAS determination of pain at 30 minutes following intervention30 minutes

Secondary

MeasureTime frame
Numeric scale report or pain Number of prescribed analgesic pills taken24-36 hours following intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026